Cystic Fibrosis Foundation Therapeutics

March 22, 2017March 22, 2017

Sound Pharma Awarded $1.6M to Test Therapy for Hearing Loss in CF Patients

Cystic Fibrosis, News

Sound Pharmaceuticals was recently awarding funding up to $1.6 million to support the early development of its lead drug candidate SPI-1005 for cystic fibrosis (CF) patients who are taking the ... Read more

July 1, 2016July 1, 2016

Cystic Fibrosis Foundation Therapeutics Grants $1.7 Million For Development of New Antimicrobial Drug

Cystic Fibrosis, News

Cystic Fibrosis Foundation Therapeutics (CFFT) based in Maryland, and Alaxia SAS in France, have entered an agreement to help support the first-in-patient clinical trial of ALX-009, an inhaled antimicrobial drug for patients with ... Read more

June 29, 2015November 5, 2015

CFFT Awards Spyryx Biosciences to Advance Novel CF Therapy

Cystic Fibrosis, News

Spyryx Biosciences, Inc. has been granted an award from Cystic Fibrosis Foundation Therapeutics (CFFT), the non-profit drug discovery and development affiliate of the Cystic Fibrosis Foundation (CFF). The funding will be invested ... Read more